Devi Biotech Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
- Paid Up Capital ₹ 2.00 Cr
- Company Age 15 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 21.10 Cr
- Revenue Growth 38.05%
- Profit Growth 78.13%
- Ebitda 50.09%
- Net Worth 1.24%
- Total Assets -2.82%
About Devi Biotech
Devi Biotech Private Limited (DBPL) is a Private Limited Indian Non-Government Company incorporated in India on 18 August 2009 and has a history of 15 years and five months. Its registered office is in Madurai, Tamil Nadu, India.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 2.00 Cr.
The company currently has active open charges totaling ₹21.10 Cr.
Utham Theenachandran, Vasanthi Theenachandran, and Theenachandran Rathinasamy serve as directors at the Company.
Company Details
-
Location
Madurai, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24100TN2009PTC072597
-
Company No.
072597
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
18 Aug 2009
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Devi Biotech?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Theenachandran Rathinasamy
|
Managing Director | 18-Aug-2009 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Utham Theenachandran
|
Director | 01-Apr-2016 | Current |
|
Vasanthi Theenachandran
|
Director | 18-Aug-2009 | Current |
Financial Performance of Devi Biotech.
Devi Biotech Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 38.05% increase. The company also saw a substantial improvement in profitability, with a 78.13% increase in profit. The company's net worth moved up by a moderate rise of 1.24%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Devi Biotech?
In 2023, Devi Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Devi Cropscience Private LimitedUtham Theenachandran, Vasanthi Theenachandran and 1 more are mutual person
-
-
Devi Plantations Private LimitedUtham Theenachandran, Vasanthi Theenachandran and 1 more are mutual person
-
Devi Plasto Pack Private Limited
Vasanthi Theenachandran and Theenachandran Rathinasamy are mutual person
Charges (Loans)
₹21.10 Cr
₹0
Charges Breakdown by Lending Institutions
- Canara Bank : 21.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 Aug 2012 | Canara Bank | ₹21.10 Cr | Open |
How Many Employees Work at Devi Biotech?
Unlock and access historical data on people associated with Devi Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Devi Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Devi Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.